Couchbase Announces Fourth Quarter and Fiscal 2022 Financial Results
"We finished our first fiscal year as a public company with strong momentum including ARR of
Fourth Quarter Fiscal 2022 Financial Highlights
- Revenue: Total revenue for the quarter was
$35.1 million , an increase of 19% year-over-year. Subscription revenue for the quarter was$32.8 million , an increase of 17% year-over-year. - Annual recurring revenue (ARR): Total ARR as of
January 31, 2022 was$132.9 million , an increase of 23% year-over-year. See the section titled "Key Business Metrics" below for details. - Gross margin: Gross margin for the quarter was 88.2%, compared to 89.4% for the fourth quarter of fiscal 2021. Non-GAAP gross margin for the quarter was 88.7%, compared to 89.5% for the fourth quarter of fiscal 2021. See the section titled "Use of Non-GAAP Financial Measures" and the tables titled "Reconciliation of GAAP to Non-GAAP Results" below for details.
- Loss from operations: Loss from operations for the quarter was
$12.7 million , compared to$8.0 million for the fourth quarter of fiscal 2021. Non-GAAP operating loss for the quarter was$9.1 million , compared to$6.7 million for the fourth quarter of fiscal 2021. - Cash flow: Cash flows used in operating activities for the quarter were
$2.7 million , compared to$6.6 million in the fourth quarter of fiscal 2021. Capital expenditures were less than$0.1 million during the quarter, leading to negative free cash flow of$2.7 million , compared to negative free cash flow of$6.6 million in the fourth quarter of fiscal 2021. - Remaining performance obligations (RPO): RPO as of
January 31, 2022 was$161.6 million , an increase of 58% year-over-year.
Full Year Fiscal 2022 Financial Highlights
- Revenue: Total revenue for the year was
$123.5 million , an increase of 20% year-over-year. Subscription revenue for the year was$116.3 million , an increase of 20% year-over-year. - Gross margin: Gross margin for the year was 88.0%, compared to 88.8% for fiscal 2021. Non-GAAP gross margin for the year was 88.4%, compared to 88.9% for fiscal 2021.
- Loss from operations: Loss from operations for the year was
$56.3 million , compared to$33.1 million for fiscal 2021. Non-GAAP operating loss for the year was$45.5 million , compared to$28.2 million for fiscal 2021. - Cash flow: Cash flows used in operating activities for the year were
$41.6 million , compared to$39.2 million in fiscal 2021. Capital expenditures were$0.8 million during the year, leading to negative free cash flow of$42.4 million , compared to negative free cash flow of$42.0 million in fiscal 2021.
Recent Business Highlights
- Appointed cloud and database veteran
Gopi Duddi as senior vice president of Engineering, overseeing all product development and delivery for the company. Duddi brings nearly 25 years of experience and, as a former general manager at AWS, built and supported some of the cloud service provider's fastest growing products. - Announced Couchbase Mobile 3, an edge-ready data platform that empowers mobile developers and edge architects to build fully native, modern applications in the cloud, at the edge and on mobile and IoT devices using the language, frameworks and platform of their choice.
- Granted a
U.S. patent for cost-based optimization for document-oriented database queries, makingCouchbase the only document database and cloud company to hold a patent for this novel and critical query optimization method. - Achieved the
Amazon Web Services (AWS) Outposts Ready designation, recognizing thatCouchbase has demonstrated successful integration with AWS Outposts deployments. This achievement further strengthensCouchbase's mobile and edge partner ecosystem to provide a superior experience for customers. - Named one of the top five out of 25 highest-rated public cloud computing companies to work for in a list released by
Battery Ventures with data specifically provided by Glassdoor.
Financial Outlook
For the first quarter of fiscal 2023,
- Total revenue between
$32.5 million and$32.7 million - Total ARR between
$136 million and$138 million - Non-GAAP operating loss between
$16.8 million and$16.6 million
For the full fiscal year 2023,
- Total revenue between
$146.5 million and$147.5 million - Total ARR between
$160 million and$164 million - Non-GAAP operating loss between
$57.2 million and$56.2 million
The guidance provided above is based on several assumptions that are subject to change and many of which are outside our control. If actual results vary from these assumptions, our expectations may change. There can be no assurance that we will achieve these results.
Conference Call Information
About
At
Use of Non-GAAP Financial Measures
In addition to our financial information presented in accordance with GAAP, we believe certain non-GAAP financial measures are useful to investors in evaluating our operating performance. We use certain non-GAAP financial measures, collectively, to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, may be helpful to investors because they provide consistency and comparability with past financial performance and meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. Non-GAAP financial measures are presented for supplemental informational purposes only, have limitations as analytical tools and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP and may be different from similarly-titled non-GAAP financial measures used by other companies. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures (provided in the financial statement tables included in this press release), and not to rely on any single financial measure to evaluate our business.
Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating loss, non-GAAP operating margin, non-GAAP net loss attributable to common stockholders and non-GAAP net loss per share attributable to common stockholders: We define these non-GAAP financial measures as their respective GAAP measures, excluding expenses related to stock-based compensation expense and litigation-related expenses. We use these non-GAAP financial measures in conjunction with GAAP measures to assess our performance, including in the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies and to communicate with our board of directors concerning our financial performance.
Free cash flows: We define free cash flow as cash used in operating activities less purchases of property and equipment, which includes capitalized internal-use software costs. We believe free cash flow is a useful indicator of liquidity that provides our management, board of directors and investors with information about our future ability to generate or use cash to enhance the strength of our balance sheet and further invest in our business and pursue potential strategic initiatives.
Please see the reconciliation tables at the end of this press release for the reconciliation of GAAP and non-GAAP results.
Key Business Metrics
We review a number of operating and financial metrics, including ARR, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions.
We define ARR as of a given date as the annualized recurring revenue that we would contractually receive from our customers in the month ending 12 months following such date.
Based on historical experience with customers, we assume all contracts will be automatically renewed at the same levels unless we receive notification of non-renewal and are no longer in negotiations prior to the measurement date. ARR excludes revenue from on-demand arrangements. Although we seek to increase ARR as part of our strategy of targeting large enterprise customers, this metric may fluctuate from period to period based on our ability to acquire new customers and expand within our existing customers. We believe that our ARR is an important indicator of the growth and performance of our business.
Forward-Looking Statements
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management's beliefs and assumptions and on information currently available to management. Forward-looking statements include, but are not limited to, quotations of management, the section titled "Financial Outlook" above and statements about
Condensed Consolidated Statements of Operations (in thousands, except per share data) (unaudited) |
|||||||||
Three Months Ended |
Year Ended |
||||||||
2022 |
2021 |
2022 |
2021 |
||||||
Revenue: |
|||||||||
License |
$ 6,540 |
$ 5,482 |
$ 19,008 |
$ 14,032 |
|||||
Support and other |
26,245 |
22,557 |
97,279 |
82,904 |
|||||
Total subscription revenue |
32,785 |
28,039 |
116,287 |
96,936 |
|||||
Services |
2,279 |
1,388 |
7,255 |
6,349 |
|||||
Total revenue |
35,064 |
29,427 |
123,542 |
103,285 |
|||||
Cost of revenue: |
|||||||||
Subscription(1) |
2,311 |
1,961 |
8,529 |
6,074 |
|||||
Services(1) |
1,817 |
1,160 |
6,252 |
5,543 |
|||||
Total cost of revenue |
4,128 |
3,121 |
14,781 |
11,617 |
|||||
Gross profit |
30,936 |
26,306 |
108,761 |
91,668 |
|||||
Operating expenses: |
|||||||||
Research and development(1) |
13,372 |
10,612 |
51,639 |
39,000 |
|||||
Sales and marketing(1) |
23,658 |
19,103 |
89,372 |
70,248 |
|||||
General and administrative(1) |
6,574 |
4,595 |
24,008 |
15,500 |
|||||
Total operating expenses |
43,604 |
34,310 |
165,019 |
124,748 |
|||||
Loss from operations |
(12,668) |
(8,004) |
(56,258) |
(33,080) |
|||||
Interest expense |
(26) |
(2,208) |
(656) |
(6,970) |
|||||
Other income (expense), net |
(256) |
890 |
(300) |
1,111 |
|||||
Loss before income taxes |
(12,950) |
(9,322) |
(57,214) |
(38,939) |
|||||
Provision for income taxes |
286 |
325 |
1,015 |
1,044 |
|||||
Net loss |
$ (13,236) |
$ (9,647) |
$ (58,229) |
$ (39,983) |
|||||
Cumulative dividends on Series G redeemable convertible preferred stock |
— |
(1,480) |
(2,917) |
(4,076) |
|||||
Net loss attributable to common stockholders |
$ (13,236) |
$ (11,127) |
$ (61,146) |
$ (44,059) |
|||||
Net loss per share attributable to common stockholders, basic and diluted |
$ (0.30) |
$ (1.90) |
$ (2.37) |
$ (7.71) |
|||||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
43,688 |
5,852 |
25,777 |
5,717 |
|||||
(1) Includes stock-based compensation expense as follows: |
|||||||||
Three Months Ended |
Year Ended |
||||||||
2022 |
2021 |
2022 |
2021 |
||||||
Cost of revenue—subscription |
$ 73 |
$ 19 |
$ 196 |
$ 69 |
|||||
Cost of revenue—services |
80 |
13 |
196 |
54 |
|||||
Research and development |
1,119 |
348 |
3,343 |
1,316 |
|||||
Sales and marketing |
1,447 |
523 |
3,968 |
1,536 |
|||||
General and administrative |
868 |
426 |
3,047 |
1,696 |
|||||
Total stock-based compensation expense |
$ 3,587 |
$ 1,329 |
$ 10,750 |
$ 4,671 |
Condensed Consolidated Balance Sheets (in thousands) (unaudited) |
|||
As of |
|||
2022 |
2021 |
||
Assets |
|||
Current assets |
|||
Cash and cash equivalents |
$ 95,688 |
$ 37,297 |
|
Short-term investments |
110,266 |
19,546 |
|
Accounts receivable, net |
36,696 |
35,897 |
|
Deferred commissions |
11,783 |
8,353 |
|
Prepaid expenses and other current assets |
8,559 |
2,449 |
|
Total current assets |
262,992 |
103,542 |
|
Property and equipment, net |
4,288 |
6,506 |
|
Deferred commissions, noncurrent |
8,243 |
4,941 |
|
Other assets |
1,219 |
2,199 |
|
Total assets |
$ 276,742 |
$ 117,188 |
|
Liabilities, Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) |
|||
Current liabilities |
|||
Accounts payable |
$ 1,923 |
$ 2,428 |
|
Accrued compensation and benefits |
16,143 |
9,110 |
|
Other accrued liabilities |
3,231 |
4,154 |
|
Deferred revenue |
69,010 |
57,168 |
|
Total current liabilities |
90,307 |
72,860 |
|
Long-term debt |
— |
24,948 |
|
Deferred revenue, noncurrent |
2,713 |
4,542 |
|
Other liabilities |
507 |
1,358 |
|
Total liabilities |
93,527 |
103,708 |
|
Redeemable convertible preferred stock |
— |
259,822 |
|
Stockholders' equity (deficit) |
|||
Preferred stock |
— |
— |
|
Common stock |
— |
— |
|
Additional paid-in capital |
525,392 |
37,410 |
|
Accumulated other comprehensive income (loss) |
(195) |
1 |
|
Accumulated deficit |
(341,982) |
(283,753) |
|
Total stockholders' equity (deficit) |
183,215 |
(246,342) |
|
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) |
$ 276,742 |
$ 117,188 |
Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited) |
|||||||
Three Months Ended |
Year Ended |
||||||
2022 |
2021 |
2022 |
2021 |
||||
Cash flows from operating activities |
|||||||
Net loss |
$ (13,236) |
$ (9,647) |
$ (58,229) |
$ (39,983) |
|||
Adjustments to reconcile net loss to net cash used in operating activities |
|||||||
Depreciation and amortization |
710 |
698 |
2,824 |
2,006 |
|||
Amortization of debt issuance costs |
— |
240 |
52 |
717 |
|||
Debt prepayment costs |
— |
625 |
— |
1,000 |
|||
Stock-based compensation |
3,587 |
1,329 |
10,750 |
4,671 |
|||
Amortization of deferred commissions |
3,940 |
3,316 |
13,763 |
10,402 |
|||
Foreign currency transaction (gains) losses |
377 |
(742) |
382 |
(931) |
|||
Other |
164 |
62 |
267 |
132 |
|||
Changes in operating assets and liabilities |
|||||||
Accounts receivable |
(14,289) |
(17,616) |
(730) |
(5,524) |
|||
Deferred commissions |
(8,867) |
(5,046) |
(20,495) |
(13,450) |
|||
Prepaid expenses and other assets |
(333) |
1,379 |
(6,217) |
56 |
|||
Accounts payable |
(1,604) |
282 |
(491) |
925 |
|||
Accrued compensation and benefits |
6,213 |
1,611 |
7,030 |
298 |
|||
Accrued expenses and other liabilities |
(86) |
602 |
(493) |
(279) |
|||
Deferred revenue |
20,772 |
16,338 |
10,013 |
782 |
|||
Net cash used in operating activities |
(2,652) |
(6,569) |
(41,574) |
(39,178) |
|||
Cash flows from investing activities |
|||||||
Purchases of short-term investments |
(46,200) |
(6,348) |
(112,479) |
(20,493) |
|||
Maturities and sales of short-term investments |
1,800 |
900 |
21,268 |
900 |
|||
Purchases of property and equipment |
(5) |
(49) |
(819) |
(2,819) |
|||
Net cash used in investing activities |
(44,405) |
(5,497) |
(92,030) |
(22,412) |
|||
Cash flows from financing activities |
|||||||
Payments of debt |
— |
(25,625) |
(25,000) |
(57,402) |
|||
Proceeds from issuance of debt, net of issuance costs |
— |
25,000 |
— |
31,402 |
|||
Proceeds from issuance of Series G redeemable convertible preferred stock, net of issuance costs |
— |
— |
— |
104,316 |
|||
Proceeds from exercise of stock options |
1,562 |
1,699 |
7,495 |
2,185 |
|||
Proceeds from initial public offering, net of underwriting discounts and commissions |
— |
— |
214,854 |
— |
|||
Payment for fractional shares in reverse stock split |
— |
— |
(9) |
— |
|||
Payments of deferred offering costs |
— |
— |
(4,930) |
— |
|||
Net cash provided by financing activities |
1,562 |
1,074 |
192,410 |
80,501 |
|||
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(257) |
168 |
(415) |
162 |
|||
Net increase (decrease) in cash, cash equivalents and restricted cash |
(45,752) |
(10,824) |
58,391 |
19,073 |
|||
Cash, cash equivalents, and restricted cash at beginning of period |
141,983 |
48,664 |
37,840 |
18,767 |
|||
Cash, cash equivalents, and restricted cash at end of period |
$ 96,231 |
$ 37,840 |
$ 96,231 |
$ 37,840 |
|||
Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown above: |
|||||||
Cash and cash equivalents |
$ 95,688 |
$ 37,297 |
$ 95,688 |
$ 37,297 |
|||
Restricted cash included in other assets |
543 |
543 |
543 |
543 |
|||
Total cash, cash equivalents and restricted cash |
$ 96,231 |
$ 37,840 |
$ 96,231 |
$ 37,840 |
Reconciliation of GAAP to Non-GAAP Results (in thousands, except per share data) (unaudited) |
|||||||
Three Months Ended |
Year Ended |
||||||
2022 |
2021 |
2022 |
2021 |
||||
Reconciliation of GAAP gross profit to non-GAAP gross profit: |
|||||||
Total revenue |
$ 35,064 |
$ 29,427 |
$ 123,542 |
$ 103,285 |
|||
Gross profit |
$ 30,936 |
$ 26,306 |
$ 108,761 |
$ 91,668 |
|||
Add: Stock-based compensation expense |
153 |
32 |
392 |
123 |
|||
Non-GAAP gross profit |
$ 31,089 |
$ 26,338 |
$ 109,153 |
$ 91,791 |
|||
Gross margin |
88.2 % |
89.4 % |
88.0 % |
88.8 % |
|||
Non-GAAP gross margin |
88.7 % |
89.5 % |
88.4 % |
88.9 % |
|||
Three Months Ended |
Year Ended |
||||||
2022 |
2021 |
2022 |
2021 |
||||
Reconciliation of GAAP operating expenses to non-GAAP operating expenses: |
|||||||
GAAP research and development |
$ 13,372 |
$ 10,612 |
$ 51,639 |
$ 39,000 |
|||
Less: Stock-based compensation expense |
(1,119) |
(348) |
(3,343) |
(1,316) |
|||
Non-GAAP research and development |
$ 12,253 |
$ 10,264 |
$ 48,296 |
$ 37,684 |
|||
GAAP sales and marketing |
$ 23,658 |
$ 19,103 |
$ 89,372 |
$ 70,248 |
|||
Less: Stock-based compensation expense |
(1,447) |
(523) |
(3,968) |
(1,536) |
|||
Non-GAAP sales and marketing |
$ 22,211 |
$ 18,580 |
$ 85,404 |
$ 68,712 |
|||
GAAP general and administrative |
$ 6,574 |
$ 4,595 |
$ 24,008 |
$ 15,500 |
|||
Less: Stock-based compensation expense |
(868) |
(426) |
(3,047) |
(1,696) |
|||
Less: Litigation-related expenses |
— |
— |
— |
(213) |
|||
Non-GAAP general and administrative |
$ 5,706 |
$ 4,169 |
$ 20,961 |
$ 13,591 |
|||
Three Months Ended |
Year Ended |
||||||
2022 |
2021 |
2022 |
2021 |
||||
Reconciliation of GAAP operating loss to non-GAAP operating loss: |
|||||||
Total revenue |
$ 35,064 |
$ 29,427 |
$ 123,542 |
$ 103,285 |
|||
Loss from operations |
$ (12,668) |
$ (8,004) |
$ (56,258) |
$ (33,080) |
|||
Add: Stock-based compensation expense |
3,587 |
1,329 |
10,750 |
4,671 |
|||
Add: Litigation-related expenses |
— |
— |
— |
213 |
|||
Non-GAAP operating loss |
$ (9,081) |
$ (6,675) |
$ (45,508) |
$ (28,196) |
|||
Operating margin |
(36) % |
(27) % |
(46) % |
(32) % |
|||
Non-GAAP operating margin |
(26) % |
(23) % |
(37) % |
(27) % |
Three Months Ended |
Year Ended |
||||||
2022 |
2021 |
2022 |
2021 |
||||
Reconciliation of GAAP net loss attributable to common stockholders to non-GAAP net loss attributable to common stockholders: |
|||||||
Net loss attributable to common stockholders |
$ (13,236) |
$ (11,127) |
$ (61,146) |
$ (44,059) |
|||
Add: Stock-based compensation expense |
3,587 |
1,329 |
10,750 |
4,671 |
|||
Add: Litigation-related expenses |
— |
— |
— |
213 |
|||
Non-GAAP net loss attributable to common stockholders |
$ (9,649) |
$ (9,798) |
$ (50,396) |
$ (39,175) |
|||
GAAP net loss per share attributable to common stockholders |
$ (0.30) |
$ (1.90) |
$ (2.37) |
$ (7.71) |
|||
Non-GAAP net loss per share attributable to common stockholders |
$ (0.22) |
$ (1.67) |
$ (1.96) |
$ (6.85) |
|||
Weighted average shares outstanding, basic and diluted |
43,688 |
5,852 |
25,777 |
5,717 |
The following table presents a reconciliation of free cash flow to net cash used in operating activities, the most directly comparable GAAP measure, for each of the periods indicated (in thousands, unaudited):
Three Months Ended |
Year Ended |
||||||
2022 |
2021 |
2022 |
2021 |
||||
Net cash used in operating activities |
$ (2,652) |
$ (6,569) |
$ (41,574) |
$ (39,178) |
|||
Less: Purchases of property and equipment |
(5) |
(49) |
(819) |
(2,819) |
|||
Free cash flow |
$ (2,657) |
$ (6,618) |
$ (42,393) |
$ (41,997) |
|||
Net cash used in investing activities |
$ (44,405) |
$ (5,497) |
$ (92,030) |
$ (22,412) |
|||
Net cash provided by financing activities |
$ 1,562 |
$ 1,074 |
$ 192,410 |
$ 80,501 |
Key Business Metrics (in millions) (unaudited) |
||||||||||||
As of |
||||||||||||
|
|
|
|
|
|
|||||||
2020 |
2021 |
2021 |
2021 |
2021 |
2022 |
|||||||
Annual Recurring Revenue |
$ 101.4 |
$ 107.8 |
$ 109.5 |
$ 115.2 |
$ 122.3 |
$ 132.9 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/couchbase-announces-fourth-quarter-and-fiscal-2022-financial-results-301499308.html
SOURCE
Investor Contact: Edward Parker, ICR for Couchbase, IR@couchbase.com; Media Contact: Michelle Lazzar, Couchbase Communications, CouchbasePR@couchbase.com